Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD)_Juniper Publishers
Authored by
Somchai Amornyotin
Abstract
Gastrointestinal endoscopy (GIE) is a procedure for
diagnosis and treatment of gastrointestinal tract abnormalities. To
date, intravenous sedation is commonly used for this procedure. The new
sedative drugs and equipment for safety and efficacy are available. This
mini-review focuses on innovation in intravenous sedation (IVS) for GIE
procedures.
Abbreviations: IVS:Intravenous Sedation; GIE: Gastrointestinal Endoscopy; TCI: Target-Controlled Infusion; PCS: Patient-Controlled Sedation; CAPS: Computer-Assisted Personalized Sedation
Introduction
Intravenous Sedation (IVS) is one of the important
components of gastrointestinal endoscopic (GIE) procedures. The aim of
sedation for these procedures is to improve patient's comfort and
endoscopic practice as well as patient and endoscopist satisfaction. The
depth of sedation level is dependent on the type and duration of
endoscopy, experience of endoscopist, and patient's physical status. The
sedation regimens for GIE procedures are quite different. To date,
several sedation techniques are utilized. The new sedative drugs and
equipment for safety and efficacy are available [1-4].
Target-Controlled Infusion
Target-controlled infusion (TCI) is a sophisticated
tool for providing optimal sedation regimen avoiding under or over
sedation in GIE procedures. This technique uses a pharmacokinetic model
to predictthe patient plasma and effect site concentrations from the
infusion design and allows the anesthesiologist to target a selected
concentration. The device computes the appropriate infusion system to
achieve this concentration [5].
The TCI rapidly accomplishes and maintains a predefined plasma or
effect site concentration of the anesthetic drug. Presently, TCI devices
for propofol administration are approved in several countries. A
previous study determined the quality and plausibility of TCI as a
sedation mechanism for upper and lower GIE procedures.This study
confirmed that TCI sedation for GIE provided safe and effective sedation
and was associated with a better sedation quality [6].
Wang and colleagues evaluated whether TCI of propofol could offer a
better sedation quality than manually controlled infusion in training
inexperienced anesthesiology residents. The authors concluded that TCI
was a more effective and safer technique for anesthesiology residents in
sedation for colonoscopy [7].
Patient-Controlled Sedation
Patient-controlled sedation (PCS) usually involves a
targetcontrolled method. There are two types of PCS. In open-loop
system, the sedation is adjusted according to a target drug
concentration. In closed-loop system, the patient directs the infusion
system to release medication up to a set point. A systematic review and
meta-analysis assessed the advantages and disadvantages between PCS and
traditional IVS. The review demonstrated that PCS was as feasible and
effective as traditional IVS for colonoscopy. PCS relatively shows its
superiority in recovery time, incidence for oxygen saturation and
hypotension [8].
Recently, PCS is readily implemented in clinical practice. It is
suitable for IVS in younger and low-risk patients and is associated with
less cardio respiratory adverse effects [9].
Adding propofol to remifentanil or alfentanil increases sedation, and
potentiates analgesia, with no increase in respiratory depression. The
combination regimen is a safe and feasible method for PCS [10].
A prospective, randomized, controlled study compared
the use of PCS with propofol and remifentanil and the anesthesiologist-
administered propofol sedation for 80 elective endoscopic patients. All
patients were completely successful except two patients in the PCS
group. Mean level of sedation and total propofol requirement in the PCS
group were significantly lower than in the anesthesiologist-
administered propofol group. The study confirmed that PCS with propofol
and remifentanilwas a safe and well-accepted sedation technique for
endoscopic patients [11].
Moreover, time to sedation and the recovery time in the PCS with the
propofol and remifentanil group were significantly shorter than in the
PCS with the fentanyl and midazolam group. However, the perceptions of
patients, nurses and endoscopists were comparable between the two groups
[12].
Computer-Assisted Personalized Sedation
Computer-assisted personalized sedation (CAPS) is a
sedation delivery system to administer propofol. It is based on
thepatient response to stimulation and physiologic profiles. It presents
an attractive means ofdelivering safe and effective doses of propofol.
The closed-loop target-controlled system orcontinuous
electroencephalographic recordings are used to assess the depth of
sedation. Patient-controlledplatforms may also be used. These devices
may help physicians titrating propofol administrationand controlling the
physiological functions. The American Society for Gastrointestinal
Endoscopy Technology Committee provides reviews of this system that have
the potential to have an impact on the practice of GIE [13].
Several previous studies demonstrated the feasibility of CAPS for
facilitating the accurate administration of propofol by endoscopist or
nurse teams, achieving minimal to moderate sedation in patients
undergoing routine GIE procedures. Mean propofol dosage was low and
post-procedure recovery time was rapid [14].
The SEDASYS System is a CAPS device that delivers the
drug propofol for minimal-to-moderate sedation. The device provides
comprehensive patient monitoring and limits the depth of sedation by
adjusting drug delivery accordingly. The efficacy and safety of this
system for sedation during GIE procedures was evaluated and compared
with the combination of benzodiazepineand opioid in adult patients with
ASA physical status class I-III. All patients were sedated in mild to
moderate depth of sedation level. The study confirmed that SEDASYS
system was safe and effective for sedation during GIE procedures.
Patient and physician satisfaction as well as recovery time in the
SEDASYS group were significantly better than in the combination of
benzodiazepine and opioid group [15].
The use of CAPS system by non-anesthetic personnel for mild or moderate
sedation in GIE patients was also safe and effective [14].
Conclusion
GIE procedure requires some forms of anesthesia. IVS
is commonly used for this procedure. Sedation could be effectively and
safely performed by anesthesiologist or non-anesthetic personnel with
appropriate patient selection and monitoring. The new sedative drugs and
equipment are available. However, preanesthetic assessment and
preparation, anesthetic drugs used, monitoring practices and
post-anesthesia management are still essential for the anesthesia
innovation in GIE procedures.
To Know More About Advanced Research in Gastroenterology &
Hepatology Journal
click on:
https://juniperpublishers.com/argh/index.php
https://juniperpublishers.com/argh/index.php
Comments
Post a Comment